Alx Oncology Holdings Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
ALXO chart
What traders are saying about $ALXO
Latest postsAlx Oncology Holdings Inc news
- ALX Oncology Holdings Inc. Estimates – NASDAQ:ALXO
TradingView ·
- ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
Yahoo Finance ·
- ALX Oncology to Present at Upcoming Investor Conferences in September
Yahoo Finance ·
- Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
- ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?
Yahoo Finance ·
- ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Yahoo Finance ·
- ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
Yahoo Finance ·
- ALX Oncology Targets Key Readouts to Advance CD47, EGFR Cancer Drug Programs
marketbeat.com ·
- ALX Oncology (ALXO) Q1 2026 Earnings Transcript
fool.com ·
- Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
Yahoo Finance ·
- ALX Oncology Holdings Inc. Q1 2026 Earnings Call Summary
app.moby.co ·
Alx Oncology Holdings Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $0 |
| Net income | -$101.7M | -$134.8M | -$160.8M | -$123.5M |
| Diluted EPS | $-1.90 | $-2.58 | $-3.74 | $-3.03 |
| Total assets (year end) | $59.0M | $147.8M | $242.6M | $306.5M |
| Cash and equivalents (year end) | $16.4M | $17.6M | $22.4M | $48.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Alx Oncology Holdings Inc
- Ticker
- ALXO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1810182
Frequently asked questions
What exchange is Alx Oncology Holdings Inc listed on?
Alx Oncology Holdings Inc trades on the Nasdaq under the ticker symbol ALXO.
What industry is Alx Oncology Holdings Inc in?
Alx Oncology Holdings Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Alx Oncology Holdings Inc headquartered?
Alx Oncology Holdings Inc's business address on file with the SEC is in South San Francisco, CA.
When does Alx Oncology Holdings Inc's fiscal year end?
Alx Oncology Holdings Inc's fiscal year ends on December 31.
How much revenue did Alx Oncology Holdings Inc report?
Alx Oncology Holdings Inc reported $0 in revenue for calendar year 2022, according to its SEC filings.